Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation

Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06510.

To assess the effects of early thrombolytic therapy on the incidence of clinical and induced ventricular arrhythmias in high risk postmyocardial infarction patients, 32 patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation were prospectively evaluated. Sixteen patients (Group A) received routine care because of contraindication to thrombolytic therapy or other factors and 16 (Group B) received either tissue plasminogen activator or streptokinase within 6 h of the onset of chest pain. The two groups were similar in left ventricular ejection fraction (mean +/- SD, 28 +/- 9% [Group A] versus 30 +/- 8% [Group B]) and occurrence of spontaneous nonsustained ventricular tachycardia, new bundle branch block and congestive heart failure. Group B patients had higher peak creatine kinase MB levels (446 +/- 336 versus 205 +/- 120 IU; p = 0.017) and earlier time to peak creatine kinase values (13.4 +/- 6.6 versus 19.1 +/- 6.1 h; p = 0.006). Twenty patients who had no clinical sustained ventricular arrhythmias underwent electrophysiologic study 13 +/- 6 days after infarction. Ventricular tachycardia was induced during the study in 7 (88%) of 8 Group A patients, but in only 1 (8%) of 12 Group B patients given thrombolytic therapy (p = 0.0008). During a mean follow-up period of 11 +/- 8 months, eight Group A patients (50%) died suddenly or were resuscitated from sustained ventricular tachycardia; all Group B patients are alive and have had no clinical arrhythmic events (p = 0.002).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				P. Pascale, P. Taffe, C. Regamey, L. Kappenberger, and M. Fromer Reduced Ejection Fraction After Myocardial Infarction: Is It Sufficient To Justify Implantation of a Defibrillator? Chest, October 1, 2005; 128(4): 2626 - 2632. [Abstract] [Full Text] [PDF]

				F. Wellens, P. Geelen, E. Demirsoy, F. Van Praet, R. De Geest, I. Degrieck, H. Vanermen, and P. Brugada Surgical treatment of tachyarrhythmias due to postinfarction left ventricular aneurysm with endoaneurysmorrhaphy and cryoablation Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 771 - 776. [Abstract] [Full Text] [PDF]

				F. Van de Werf New aspects of pharmacological reperfusion: from macro- to microlysis Eur. Heart J. Suppl., June 1, 2001; 3(suppl_C): C62 - C68. [Abstract] [PDF]

				C. Bauters, M. Delomez, E. Van Belle, E. McFadden, J.-M. Lablanche, and M. E. Bertrand Angiographically Documented Late Reocclusion After Successful Coronary Angioplasty of an Infarct-Related Lesion Is a Powerful Predictor of Long-Term Mortality Circulation, May 4, 1999; 99(17): 2243 - 2250. [Abstract] [Full Text] [PDF]

				C. F. Opitz, P. V. Finn, M. A. Pfeffer, G. F. Mitchell, and J. M. Pfeffer Effects of reperfusion on arrhythmias and death after coronary artery occlusion in the rat: increased electrical stability independent of myocardial salvage J. Am. Coll. Cardiol., July 1, 1998; 32(1): 261 - 267. [Abstract] [Full Text] [PDF]

				C. A. Schneider, E. Voth, F. M. Baer, M. Horst, R. Wagner, and U. Sechtem QT Dispersion Is Determined by the Extent of Viable Myocardium in Patients With Chronic Q-Wave Myocardial Infarction Circulation, December 2, 1997; 96(11): 3913 - 3920. [Abstract] [Full Text]

				C. Bauters, J.-M. Lablanche, E. Van Belle, R. Niculescu, T. Meurice, E. P. Mc Fadden, and M. E. Bertrand Effects of Coronary Stenting on Restenosis and Occlusion After Angioplasty of the Culprit Vessel in Patients With Recent Myocardial Infarction Circulation, November 4, 1997; 96(9): 2854 - 2858. [Abstract] [Full Text]

				D. Mehta, J. Curwin, J. A. Gomes, and V. Fuster Sudden Death in Coronary Artery Disease : Acute Ischemia Versus Myocardial Substrate Circulation, November 4, 1997; 96(9): 3215 - 3223. [Full Text]

				W. G. Stevenson and P. M. Ridker Should Survivors of Myocardial Infarction With Low Ejection Fraction Be Routinely Referred to Arrhythmia Specialists? JAMA, August 14, 1996; 276(6): 481 - 485. [Abstract] [PDF]

				F. K. Welty, M. A. Mittleman, S. M. Lewis, W. L. Kowalker, R. W. Healy, S. J. Shubrooks Jr, and J. E. Muller A Patent Infarct-Related Artery Is Associated With Reduced Long-term Mortality After Percutaneous Transluminal Coronary Angioplasty for Postinfarction Ischemia and an Ejection Fraction <50% Circulation, April 15, 1996; 93(8): 1496 - 1501. [Abstract] [Full Text]

				G. A. Lamas, G. C. Flaker, G. Mitchell, S. C. Smith Jr, B. J. Gersh, C.-C. Wun, L. Moye, J. L. Rouleau, J. D. Rutherford, M. A. Pfeffer, et al. Effect of Infarct Artery Patency on Prognosis After Acute Myocardial Infarction Circulation, September 1, 1995; 92(5): 1101 - 1109. [Abstract] [Full Text]

				D. W. M. Muller and E. J. Topol Selection of Patients with Acute Myocardial Infarction for Thrombolytic Therapy Ann Intern Med, December 15, 1990; 113(12): 949 - 960. [Abstract] [PDF]

				R. C. Becker Reperfusion of Nonviable Myocardium: Lessons from Thrombolytic Therapy J Intensive Care Med, January 1, 1990; 5(1): 1 - 2. [PDF]

				D. W. Krichbaum and D. A. Trivedi Thrombolytic Therapy in Acute Myocardial Infarction Journal of Pharmacy Practice, January 1, 1990; 3(5): 332 - 348. [PDF]

				A. J. Tiefenbrunn and P. A. Ludbrook Coronary Thrombolysis-- It's Worth the Risk JAMA, April 14, 1989; 261(14): 2107 - 2108. [Abstract] [PDF]